AHA Scientific Sessions 2025 Abstract
Vutrisiran Improved Outcomes Versus Placebo in Patients with Transthyretin Amyloidosis with Cardiomyopathy and Severe Chronic Kidney Disease: Post Hoc Analysis of HELIOS-B
Trial in peopleInterventions
Papers by Colleen Moffitt
1 result